These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21622243)

  • 61. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.
    Bidlingmaier S; Zhu X; Liu B
    J Mol Med (Berl); 2008 Sep; 86(9):1025-32. PubMed ID: 18535813
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prominin-1 allows prospective isolation of neural stem cells from the adult murine hippocampus.
    Walker TL; Wierick A; Sykes AM; Waldau B; Corbeil D; Carmeliet P; Kempermann G
    J Neurosci; 2013 Feb; 33(7):3010-24. PubMed ID: 23407958
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human.
    Tang X; Yao Y; Zhu J; Jin K; Wang Y; Mao Y; Zhou L
    Childs Nerv Syst; 2012 Nov; 28(11):1869-77. PubMed ID: 22814953
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Progress of research on breast cancer stem cell markers].
    Liu X; Li W; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):282-4. PubMed ID: 24915825
    [No Abstract]   [Full Text] [Related]  

  • 65. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
    Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
    Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms.
    Schittenhelm J; Simon P; Harter PN; Zachskorn C; Schlaszus H; Röttger F; Winkels M; Weller M; Meyermann R; Mittelbronn M
    Histopathology; 2011 Apr; 58(5):739-49. PubMed ID: 21438906
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD133+ human colorectal adenocarcinoma cells are resistant to staining with fluorescent dyes used for analysis of ABC transporter activities.
    Gisina AM; Lupatov AY; Karalkin PA; Mainovskaya OA; Petrov LO; Sidorov DV; Frank GA; Yarygin KN
    Bull Exp Biol Med; 2014 Nov; 158(1):80-3. PubMed ID: 25403403
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identifying tumor stem-like cells in mouse melanoma cell lines by analyzing the characteristics of side population cells.
    Dou J; Wen P; Hu W; Li Y; Wu Y; Liu C; Zhao F; Hu K; Wang J; Jiang C; He X; Gu N
    Cell Biol Int; 2009 Aug; 33(8):807-15. PubMed ID: 19477285
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
    Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
    Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cancer stem cells in the central nervous system--a critical review.
    Prestegarden L; Enger PØ
    Cancer Res; 2010 Nov; 70(21):8255-8. PubMed ID: 20959482
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Analysis of expression of cancer stem cell-related markers in orbital adenoid cystic carcinoma].
    Lin TT; Zhu LM; He YJ; Zhang H
    Zhonghua Yan Ke Za Zhi; 2011 Aug; 47(8):703-8. PubMed ID: 22169609
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells.
    Wang B; Yu SC; Jiang JY; Porter GW; Zhao LT; Wang Z; Tan H; Cui YH; Qian C; Ping YF; Bian XW
    Stem Cell Rev Rep; 2011 Jun; 7(2):458-70. PubMed ID: 20809257
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An experimental study of dendritic cells transfected with cancer stem-like cells RNA against 9L brain tumors.
    Xiao ZY; Tang H; Xu ZM; Yan ZJ; Li P; Cai YQ; Jiang XD; Xu RX
    Cancer Biol Ther; 2011 Jun; 11(11):974-80. PubMed ID: 21502808
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer.
    Gottschling S; Schnabel PA; Herth FJ; Herpel E
    Cancer Genomics Proteomics; 2012; 9(5):275-86. PubMed ID: 22990107
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.
    Skubitz AP; Taras EP; Boylan KL; Waldron NN; Oh S; Panoskaltsis-Mortari A; Vallera DA
    Gynecol Oncol; 2013 Sep; 130(3):579-87. PubMed ID: 23721800
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma.
    Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
    J Invest Dermatol; 2013 May; 133(5):1384-7. PubMed ID: 23389394
    [No Abstract]   [Full Text] [Related]  

  • 77. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cancer stem cell labeling using poly(L-lysine)-modified iron oxide nanoparticles.
    Wang X; Wei F; Liu A; Wang L; Wang JC; Ren L; Liu W; Tu Q; Li L; Wang J
    Biomaterials; 2012 May; 33(14):3719-32. PubMed ID: 22342710
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preliminary analysis of stem cell-like cells in human neuroblastoma.
    Xing LL; Sha YL; Wu YM; Hu JM; Zhang M; Lv F
    World J Pediatr; 2015 Feb; 11(1):54-60. PubMed ID: 25431041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.